ACETYLON PHARMACEUTICALS
Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company was incorporated in 2008 and is based in Boston, Massachusetts.
ACETYLON PHARMACEUTICALS
Industry:
Biotechnology Health Care Manufacturing Medical Device Pharmaceutical
Founded:
2008-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.acetylon.com
Total Employee:
11+
Status:
Active
Contact:
(617) 245-1300
Email Addresses:
[email protected]
Total Funding:
151.25 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Proofpoint CSC Global DNS MediaMath BlueKai BlueKai DMP
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Anacor Pharmaceutical
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Celgene
Celgene investment in Private Equity Round - Acetylon Pharmaceuticals
Celgene
Celgene investment in Private Equity Round - Acetylon Pharmaceuticals
The Kraft Group
The Kraft Group investment in Series A - Acetylon Pharmaceuticals
Cobro Ventures
Cobro Ventures investment in Seed Round - Acetylon Pharmaceuticals
Official Site Inspections
http://www.acetylon.com
- Host name: 165.160.15.20
- IP address: 165.160.15.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acetylon Pharmaceuticals"
Acetylon Pharmaceuticals - Crunchbase Company …
Organization. Acetylon Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs …See details»
Acetylon Pharmaceuticals - PitchBook
Acetylon Pharmaceuticals General Information Description. Developer of small-molecule drugs designed to realize the therapeutic potential of histone deacetylase. The company is developing next-generation selective small …See details»
Organization | Acetylon Pharmaceuticals Incorporated
Acetylon Pharmaceuticals Incorporated Report issue. For profit Phase 1 Phase 2. Founded: Boston MA United States ... Organization Overview. First Clinical Trial. 2014 NCT02088398. …See details»
Acetylon Pharmaceuticals, Inc. - LinkedIn
Acetylon Pharmaceuticals, Inc. | 891 followers on LinkedIn. Acetylon Pharmaceuticals is pursuing development of next-generation, selective histone deacetylase (HDAC) enzyme inhibitors with ...See details»
Acetylon Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Acetylon Pharmaceuticals, Inc. of Summit, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Acetylon Pharmaceuticals Inc - Company Profile and News
Acetylon Pharmaceuticals, Inc. manufactures pharmaceutical products. The Company develops drugs for the treatment of cancers, inflammatory, neurodegenerative, genetic, and infectious …See details»
Acetylon Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Acetylon Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Acetylon Pharmaceuticals has 3 current employee profiles, …See details»
Acetylon Pharmaceuticals - Products, Competitors, Financials, …
Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other …See details»
Acetylon Pharmaceuticals - VentureRadar
Acetylon Pharmaceuticals believes that its next-generation, selective HDAC inhibitor compounds may accomplish enhanced clinical utility by reducing or eliminating the debilitating and …See details»
Celgene Corporation Acquires Acetylon Pharmaceuticals
Dec 2, 2016 Acetylon Pharmaceuticals today announced that it has entered into an agreement to be acquired by Celgene Corporation. Prior to the consummation of the acquisition, Acetylon …See details»
Celgene Pours $15 Million Into Acetylon Pharmaceuticals
Feb 9, 2012 BOSTON--(BUSINESS WIRE)-- Acetylon Pharmaceuticals today announced that Celgene Corporation (NASDAQ: CELG - News) will invest a total of $15 million in Acetylon via …See details»
Celgene to invest $15 million in Acetylon | Drug Discovery News
Feb 9, 2012 Acetylon Pharmaceuticals has announced that Summit, N.J.-based Celgene Corporation, a biopharmaceutical company focused on the discovery, development and …See details»
Celgene spends $100M for option to buy myeloma drug …
Jul 29, 2013 Summit, NJ-based Celgene, which initially invested $15 million in Acetylon early last year, has agreed to terms that could lead to a buyout of the startup worth $1.7 billion.See details»
Celgene Invests $15M in Acetylon to Support HDAC Inhibitor …
Feb 9, 2012 Firm’s chief commercial officer appointed as nonvoting observer to Acetylon board. Celgene has made a $15 million equity investment in Acetylon through the purchase of Series …See details»
Cambridge startup launches HDAC platform with Series A
Aug 7, 2009 Cambridge, MA-based startup Acetylon Pharmaceuticals is taking the wraps off a $7.25 million Series A later today as it sets out to zero in on a lead program and demonstrate …See details»
Acetylon Pharmaceuticals Initiates New Phase 1b Clinical Trial of ...
Aug 1, 2012 Acetylon Pharmaceuticals, Inc.Walter C. Ogier, 617-245-1300President and Chief Executive OfficerorMEDIA:MacDougall Biomedical CommunicationsKari Watson, 781-235 …See details»
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop …
Aug 7, 2009 Acetylon's lead HDAC6 inhibitor program is focused on reducing or eliminating side effects common to HDAC inhibition through highly selective targeting of the HDAC6 enzyme, …See details»
First‐in‐Class Selective HDAC6 Inhibitor (ACY‐1215) Has a Highly ...
Feb 9, 2021 For stage 2, there was a plan to enroll 18 patients, of whom 8 responses were needed to attain an efficacy of 25%. Accrual to the study was terminated early after the …See details»
Acetylene - Wikipedia
Acetylene (systematic name: ethyne) is the chemical compound with the formula C 2 H 2 and structure H−C≡C−H.It is a hydrocarbon and the simplest alkyne. [8] This colorless gas is …See details»